Literature DB >> 12887445

Diazepam terminates brief but not prolonged seizures in young, naïve rats.

Howard P Goodkin1, Xianzeng Liu, Gregory L Holmes.   

Abstract

PURPOSE: Ample evidence exists from both clinical and animal studies that the success of benzodiazepine intervention during status epilepticus (SE) in the mature nervous system is inversely related to seizure duration. This relationship has not been well studied in the developing nervous system.
METHODS: The objective of this study was to investigate the relation of age and success of diazepam (DZP) treatment in the lithium-pilocarpine model of secondarily generalized seizure in the rat by using naïve rats of three age groups, roughly corresponding to the human ages of infancy (P15), adolescence (P20), and adult (P60).
RESULTS: In all age groups, the dosage of DZP that stopped the seizures at 5 min was not effective in terminating seizures at 60 min. This decline in efficacy was present as early as 15 min after seizure onset.
CONCLUSIONS: These findings demonstrate that the inverse relation between the success of benzodiazepine intervention and seizure duration is observed in young as well as in adult rats and provide further evidence that intervention for SE should commence early.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887445     DOI: 10.1046/j.1528-1157.2003.62402.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  24 in total

1.  Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Cara H Olsen; Maria F M Braga
Journal:  Neurotox Res       Date:  2017-08-03       Impact factor: 3.911

Review 2.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

3.  The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Franco Rossetti; Steven L Miller; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2014-08-25       Impact factor: 4.030

4.  The pervasive reduction of GABA-mediated synaptic inhibition of principal neurons in the hippocampus during status epilepticus.

Authors:  Hua Yu Sun; Howard P Goodkin
Journal:  Epilepsy Res       Date:  2015-11-12       Impact factor: 3.045

Review 5.  Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.

Authors:  Sandesh D Reddy; Doodipala Samba Reddy
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

6.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.

Authors:  Xin Wu; Ramkumar Kuruba; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-16       Impact factor: 4.030

7.  Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.

Authors:  Jason McMullan; Comilla Sasson; Arthur Pancioli; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

8.  The SAMUKeppra study in prehospital status epilepticus: lessons for future study.

Authors:  Andrew C Schomer; Jaideep Kapur
Journal:  Ann Transl Med       Date:  2016-12

9.  Acute neuroprotection to pilocarpine-induced seizures is not sustained after traumatic brain injury in the developing rat.

Authors:  G G Gurkoff; C C Giza; D Shin; S Auvin; R Sankar; D A Hovda
Journal:  Neuroscience       Date:  2009-08-18       Impact factor: 3.590

Review 10.  Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.

Authors:  Steven C Schachter; John Guttag; Steven J Schiff; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2009-09       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.